Professor Ido Wolf is a distinguished medical oncologist, a world-renowned expert in the diagnosis and therapy of gastrointestinal malignancies, thyroid cancer and colorectal cancer. Doctor of Medicine (MD). Clinical experience is about 30 years.
Ido Wolf is the head of the National Cancer Center and a leading specialist at Assuta, Israel’s largest hospital.
In his daily medical practice, Ido Wolf applies the latest and most progressive treatments, utilizing advanced protocols for targeted therapy or immunologic therapy, which often saves patients’ lives and significantly improves survival rates.
Ido Wolf is actively practicing, combining clinical activities with research work in the field of gastrointestinal oncology. Clinical studies led by Professor Wolf have led to the identification of a protein that inhibits the development of malignant pancreatic tumors and is potentially effective against other aggressive cancers. It turned out to be a natural hormone secreted by the kidneys and brain. Studies have shown that when this protein is administered, malignant neoplasms shrink, further stopping their spread.
Prof. Ido Wolf is a leading lecturer at Tel Aviv University, lecturing to future oncology physicians. Active participant in many professional conferences. He has prepared more than 60 presentations for scientific international symposia and published more than 40 publications covering therapeutics in oncology. Honorary member of numerous professional societies and associations.